Subclinical Atrial Fibrillation and the Risk of StrokeJeff S. Healey, Stefan H. Hohnloser, C.P. Lau et al.|New England Journal of Medicine|2012Cited by 2.1k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationJohn W. Eikelboom, Salim Yusuf, Lars Wallentin et al.|Circulation|2011Cited by 1.1k
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Salim Yusuf et al.|The Lancet|2010Cited by 1k